listing in the us?

"Tissue Therapies Ltd announced it is progressing listing in the US and Europe."

http://www.businessspectator.com.au/bs.nsf/Article/Tissue-Therapies-raises-56m-G25JV?opendocument&src=rss

I guess the above is not correct.

Now, tis announced that over $7m will be used for producing vitrogro. given that it is 'very cheap to produce', I assume it costs $1 a dose maximum. So that might mean that we are producing over $350m's worth.

I guess that this is happening as a result of negotiations and comments from possible partners. Also the fact that the price is higher per dosage too ($50-$100).

buy & hold.